Francisco Cruz

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Combination Therapy

Botulinum Toxin

Urinary Incontinence

Spinal Cord Injury

Top Venues

Journal of medical economics

Advances in urology

This page only lists publications with an associated author ORCID identifier.

Publications

Margarida Manso, João Diogo Soares, Margarida Henriques, Francisco Botelho, Carlos Silva, Francisco Cruz
Efficacy, Satisfaction, and Compliance: Insights from 15 Years of Botulinum Toxin Use for Female Urgency Urinary Incontinence. Toxins 16 (8) (2024)
Margarida Manso, João Diogo Soares, Margarida Henriques, Francisco Botelho, Carlos Silva, Francisco Cruz
Efficacy, Satisfaction, and Compliance: Insights from 15 Years of Botulinum Toxin Use for Female Urgency Urinary Incontinence. Toxins 16 (8) (2024)
Margarida Manso, João Diogo Soares, Margarida Henriques, Francisco Botelho, Carlos Silva, Francisco Cruz
Efficacy, Satisfaction, and Compliance: Insights from 15 Years of Botulinum Toxin Use for Female Urgency Urinary Incontinence. Toxins 16 (8) (2024)
Ana Catarina Neto, Mariana Santos-Pereira, Pedro Abreu-Mendes, Delminda Neves, Henrique Almeida, Francisco Cruz, Ana Charrua
The Unmet Needs for Studying Chronic Pelvic/Visceral Pain Using Animal Models. Biomedicines 11 (3) (2023)
Francisco Cruz, Natalya Danchenko, Kyle Fahrbach, Andreas Freitag, Jialu Tarpey, John Whalen
Efficacy of abobotulinumtoxinA versus onabotulinumtoxinA for the treatment of refractory neurogenic detrusor overactivity: a systematic review and indirect treatment comparison. Journal of medical economics (2023)
Francisco Cruz, Natalya Danchenko, Kyle Fahrbach, Andreas Freitag, Jialu Tarpey, John Whalen
Efficacy of abobotulinumtoxinA versus onabotulinumtoxinA for the treatment of refractory neurogenic detrusor overactivity: a systematic review and indirect treatment comparison. Journal of medical economics 26 (1) (2023)
Francisco Cruz, Natalya Danchenko, Kyle Fahrbach, Andreas Freitag, Jialu Tarpey, John Whalen
Efficacy of abobotulinumtoxinA versus onabotulinumtoxinA for the treatment of refractory neurogenic detrusor overactivity: a systematic review and indirect treatment comparison. Journal of medical economics 26 (1) (2023)
Michel I A Wyndaele, Ana Charrua, François Hervé, Patrik Aronsson, Luke Grundy, Vikram Khullar, Alan Wein, Paul Abrams, Francisco Cruz, Célia Duarte Cruz
Beyond the urothelium: Interplay between autonomic nervous system and bladder inflammation in urinary tract infection, bladder pain syndrome with interstitial cystitis and neurogenic lower urinary tract dysfunction in spinal cord injury-ICI-RS 2023. Neurourology and urodynamics (2023)
Ana Catarina Neto, Mariana Santos-Pereira, Pedro Abreu-Mendes, Delminda Neves, Henrique Almeida, Francisco Cruz, Ana Charrua
The Unmet Needs for Studying Chronic Pelvic/Visceral Pain Using Animal Models. Biomedicines 11 (3) (2023)
Pedro Abreu-Mendes, António Ferrão-Mendes, Francisco Botelho, Francisco Cruz, Rui Pinto
Effect of Intratrigonal Botulinum Toxin in Patients with Bladder Pain Syndrome/Interstitial Cystitis: A Long-Term, Single-Center Study in Real-Life Conditions. Toxins 14 (11) (2022)
Luís Vale, Ana Charrua, Helena Cavaleiro, Rita Ribeiro-Oliveira, António Avelino, Tiago Antunes-Lopes, António Albino-Teixeira, Francisco Cruz
DU Is Induced by Low Levels of Urinary ATP in a Rat Model of Partial Bladder Outlet Obstruction: The Incidence of Both Events Decreases after Deobstruction. Advances in urology 2022 (2022)
Pedro Abreu-Mendes, Aurora Costa, Ana Charrua, Rui Almeida Pinto, Francisco Cruz
The Role of Urinary VEGF in Observational Studies of BPS/IC Patients: A Systematic Review. Diagnostics (Basel, Switzerland) 12 (5) (2022)